Introduced in House Passed House Introduced in Senate Passed Senate To President Became Law

GENE Therapy Payment Act

Date Version PDF TXT
01/01/2111 Open
02/12/2020 Introduced in House Open


Picture Name From Date Type
Kurt Schrader D-OR 02/12/2020 Sponsor
David Schweikert R-AZ 02/12/2020 Cosponsor
Markwayne Mullin R-OK 02/12/2020 Cosponsor
Roger Marshall R-KS 02/12/2020 Cosponsor
Mike Kelly R-PA 02/12/2020 Cosponsor
Jason Crow D-CO 02/12/2020 Cosponsor
Ami Bera D-CA 02/12/2020 Cosponsor
Date Branch Action
02/12/2020 President Referred to the House Committee on Energy and Commerce.Action By: House of Representatives
02/12/2020 President Introduced in HouseAction By: House of Representatives
Congress - Bill Number Major Title
Branch Vote Date Yes No Not Voting

Bill TEXT Points.
This Bill has been listed with the following Subjects from Texts:
(10)AppropriationsFor fiscal year 2020 and each fiscal year thereafter, there are appropriated to the Secretary $5,000,000 for the purpose of carrying out this subsection

Schweikert) introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo amend title XIX of the Social Security Act to provide States with the option under the Medicaid program to pay for covered outpatient drugs through risk-sharing value-based agreements, and for other purposes

(7)Assessments and report to Congress(A)Assessments(i)In generalNot later than 180 days after the end of each assessment period of any risk-sharing value-based payment agreement for a State approved under this subsection, the Secretary shall conduct an evaluation of such agreement which shall include an evaluation by the Chief Actuary to determine whether program spending under the risk-sharing value-based payment agreement aligned with the projections for the agreement made under paragraph (2)(

(B)DeathIn the case of an individual described in subparagraph (A) who dies during the period described in such subparagraph, the State plan shall not be liable for any remaining payment for the unit of the covered outpatient drug administered to the individual which is owed under the agreement described in such subparagraph

End Bill TEXT Points.
Date Bill Major Title
Committee Name
Subject Type